Could micro-ultrasound make your prostate biopsy more precise? It gives your urologist detailed, real-time images of your prostate, helping them target areas that look suspicious.
MRI is still recommended before biopsy, but micro-ultrasound could give you another option in the future. The 2025 OPTIMUM trial found that a micro-ultrasound-guided biopsy strategy was non-inferior to MRI-guided fusion biopsy for detecting clinically significant prostate cancer.
What Is Micro-Ultrasound?
Micro-ultrasound is a high-resolution scan that gives your urologist a detailed, real-time view of your prostate. It can show suspicious areas that may need further investigation.
Unlike standard ultrasound, it uses a much higher frequency to produce clearer images. This means your urologist can potentially identify and target suspicious areas during your biopsy.
How Is Micro-Ultrasound Different From Standard Ultrasound?
Standard ultrasound helps your urologist see your prostate and guide the biopsy needle, but it may not clearly show cancer. Micro-ultrasound uses a much higher frequency than conventional ultrasound to provide substantially higher-resolution images of the prostate.
This clearer view may help your doctor identify suspicious areas during biopsy. However, higher-frequency ultrasound penetrates tissue less deeply, so the anterior part of a larger prostate may be harder to visualise.
What Is the PRI-MUS Score?
The PRI-MUS score helps your urologist judge how suspicious an area of your prostate looks on a micro-ultrasound scan. Scores range from 1 to 5: PRI-MUS 1–2 are considered low risk, 3 equivocal and 4–5 suspicious.
A high PRI-MUS score does not mean you have cancer. Instead, it helps your doctor decide which areas to target during your biopsy.
How Does a Micro-Ultrasound-Guided Biopsy Work?
During your micro-ultrasound scan, your urologist can see your prostate in real time and identify suspicious areas using the PRI-MUS system. They can then guide the biopsy needle directly towards those areas, sometimes alongside additional samples.
Unlike MRI fusion biopsy, your doctor does not need to match an earlier MRI image with the live ultrasound image. However, accurate targeting still depends on your urologist correctly identifying suspicious areas.
How Do Micro-Ultrasound and MRI-Guided Biopsy Differ?
Micro-ultrasound and MRI contribute differently to biopsy planning. The table below compares when imaging occurs, how suspicious areas are scored and targeted, and their current role.
| Feature | Micro-Ultrasound | MRI-Based Pathway |
| When imaging occurs | Real-time imaging can be performed during the biopsy appointment | MRI is normally performed before the biopsy |
| Suspicion score | PRI-MUS 1–5 | PI-RADS or, in NICE guidance, a 5-point Likert score |
| Targeting | Suspicious tissue can be targeted directly under real-time micro-US visualisation | MRI targets are transferred to the biopsy using fusion, cognitive targeting or other MRI-influenced methods |
| Clinically significant cancer detection | OPTIMUM found a micro-US-guided strategy non-inferior to MRI fusion-guided biopsy | Established evidence-based approach |
| Current UK role | Emerging and available in selected specialist settings | MRI remains the recommended first-line imaging investigation |
| Other information | Primarily provides real-time prostate imaging and biopsy targeting | MRI also provides established information about lesion location and local disease extent |
At present, MRI has the more established role in UK pathways, while micro-ultrasound is an emerging real-time targeting option.
Why Is MRI Currently Used Before Prostate Biopsy?
MRI helps your doctor identify suspicious areas in your prostate before a biopsy. This can improve cancer detection and may help you avoid an unnecessary biopsy.
NICE and European guidance currently recommend MRI before prostate biopsy in appropriate patients. So, if micro-ultrasound is to become a wider option for you, researchers need to show that it can match modern MRI-guided biopsy.
What Was the OPTIMUM Trial?
OPTIMUM was an international randomised trial of 802 biopsy-naive men with suspected prostate cancer. Participants were assigned to micro-ultrasound-guided biopsy, combined micro-ultrasound/MRI-guided biopsy, or MRI/conventional-ultrasound fusion-guided biopsy.
The aim was to test whether micro-ultrasound could detect Grade Group 2 or higher cancer without performing worse than MRI fusion beyond a prespecified margin.
What Did the OPTIMUM Trial Find?
Micro-ultrasound-guided biopsy met the trial’s prespecified non-inferiority criterion for detecting Grade Group 2 or higher cancer compared with MRI/conventional-ultrasound fusion biopsy.
This means its detection performance stayed within the allowed margin; it does not show that micro-ultrasound is superior or that MRI can be omitted from every diagnostic pathway.
Evidence Note
The OPTIMUM trial randomised 802 biopsy-naive men, of whom 678 underwent biopsy. Clinically significant prostate cancer was detected in approximately 47% using the micro-ultrasound-guided strategy compared with 43% using MRI/conventional-ultrasound fusion guidance. The difference was 3.52 percentage points, with a 95% confidence interval from −3.95 to 10.92 percentage points, meeting the prespecified non-inferiority criterion.
Importantly, all study groups also underwent systematic biopsy. The trial therefore supports micro-ultrasound as an effective image-guided biopsy strategy but does not prove that micro-ultrasound-targeted cores alone can replace MRI, systematic sampling or every part of the current diagnostic pathway.
What Does Non-Inferior to MRI Actually Mean?
“Non-inferior” does not mean micro-ultrasound is better than MRI. It means that, if you have a biopsy, micro-ultrasound was shown to detect clinically significant prostate cancer within the prespecified non-inferiority margin compared with MRI-guided fusion biopsy.
So, if your doctor recommends a biopsy, micro-ultrasound could give you another effective way to target suspicious areas. However, you should not assume it can replace MRI for every patient or every situation.
Do MRI and Micro-Ultrasound Detect the Same Lesions?
Not always. If you have a suspicious area, MRI may detect some cancers that micro-ultrasound misses, while micro-ultrasound may find others that MRI does not clearly show.
This means you may eventually benefit from both technologies rather than choosing one over the other. The two technologies may therefore provide complementary information when targeting suspicious areas.
Research Insight
A 2026 systematic review and meta-analysis included 22 comparative studies, covering 5,581 micro-ultrasound-targeted and 5,937 MRI-targeted biopsy assessments. Detection of Grade Group 2 or higher prostate cancer was comparable between the two approaches, with a pooled detection ratio of 1.04.
The analysis supports micro-ultrasound as a potentially useful complementary or alternative biopsy-targeting technology, but there was meaningful variation between studies. The authors concluded that further evidence on cost-effectiveness and how micro-ultrasound should fit into modern diagnostic pathways is still needed.
Could Micro-Ultrasound Replace MRI Before Biopsy?
Micro-ultrasound could potentially provide an alternative image-guided biopsy strategy in some future diagnostic pathways. However, MRI remains recommended before prostate biopsy in current UK and European guidance.
For now, you should not assume micro-ultrasound can replace MRI in every case. MRI can give your doctor additional information about your prostate and possible cancer spread.
Could MRI and Micro-Ultrasound Be Combined?
Yes. If you need a prostate biopsy, using MRI and micro-ultrasound together could help your doctor identify suspicious areas that either test might miss on its own.
The combined micro-ultrasound/MRI strategy was also non-inferior to MRI/conventional-ultrasound fusion biopsy in OPTIMUM, but the trial did not establish that combining the technologies was superior. You may not need both tests, so your doctor can decide which approach is most suitable for you.
Could Micro-Ultrasound Make Diagnosis Faster or More Accessible?
Because micro-ultrasound provides real-time imaging during biopsy and does not require MRI-to-ultrasound fusion, it could simplify workflow in some services.
However, UK pathways still recommend MRI before biopsy, and specialist equipment, trained operators and pathology capacity are still required. Trials have not yet shown that micro-ultrasound reduces routine waiting times or improves access across healthcare systems.
What Are the Main Limitations of Micro-Ultrasound?
Micro-ultrasound gives you very detailed images, but its high-frequency waves may not reach deeper areas of the prostate as well. This means some visualisation can be more difficult in the anterior part of larger prostates because the higher-frequency signal has lower tissue penetration.
You may also have a suspicious micro-ultrasound result even when no significant cancer is found on biopsy. So, while the technology is promising, your doctor still needs to consider its limitations alongside MRI and other tests.
Could Micro-Ultrasound Cause More Men to Have Unnecessary Biopsies?
Micro-ultrasound can produce false-positive suspicious findings, meaning an area may be targeted even when the biopsy does not show clinically significant cancer. This could increase the number of targeted cores or suspicious findings that ultimately prove benign.
Researchers still need to determine whether micro-ultrasound can safely be used before biopsy to identify people who could avoid sampling altogether. A low PRI-MUS score should therefore not currently be used on its own to decide that biopsy is unnecessary.
How Much Does the Operator’s Experience Matter?
Your urologist’s experience with micro-ultrasound can influence how accurately suspicious areas are identified and targeted. Because the images are interpreted in real time, training and familiarity with the technique are important.
- Image Interpretation: Your urologist needs to recognise subtle features that may suggest clinically significant prostate cancer.
- PRI-MUS Assessment: Experience can help your doctor apply the PRI-MUS scoring system consistently during your examination.
- Accurate Targeting: Skilled interpretation helps your urologist guide biopsy samples towards the most suspicious areas.
- Learning Curve: Diagnostic performance may improve as your urologist gains more experience with micro-ultrasound.
Micro-ultrasound therefore depends on both the technology and the expertise of the person using it. As its use expands, appropriate training will be important for providing you with consistent and reliable assessment.
Does Micro-Ultrasound Mean You Have to Have a Transrectal Biopsy?
No. Micro-ultrasound is the imaging method, while transrectal and transperineal describe how your biopsy needle reaches the prostate. You can therefore have micro-ultrasound-guided biopsy without automatically having a transrectal procedure.
If you need a biopsy, your doctor can discuss which route is best for you. Current EAU guidance strongly recommends the transperineal biopsy route because of infectious-risk and antibiotic-stewardship considerations.
Is Micro-Ultrasound Already Standard Practice in the UK?
No. If you are being investigated for prostate cancer in the UK, MRI is still the standard first-line scan before biopsy. Micro-ultrasound is promising, but it is not yet used routinely everywhere.
You may find it available at some specialist centres, while others continue to use MRI-guided biopsy. If your centre recommends MRI, this does not mean your care is outdated; MRI remains an established part of prostate cancer diagnosis.
UK and European Guidance Note
NICE currently recommends multiparametric MRI as the first-line investigation for suspected clinically localised prostate cancer and recommends MRI-influenced biopsy when the MRI suspicion score is sufficiently high. Micro-ultrasound is not currently recommended by NICE as a routine replacement for this MRI-first pathway.
The 2026 European Association of Urology guideline now discusses micro-ultrasound and recognises evidence showing comparable clinically significant cancer detection to MRI-targeted biopsy. However, the EAU still gives a strong recommendation to perform MRI before prostate biopsy in men with suspected organ-confined disease. It also strongly recommends the transperineal route when prostate biopsy is performed.
What Does Micro-Ultrasound Mean for You Today?
If you are being investigated for prostate cancer, your doctor will consider your PSA, age, family history and other risk factors before deciding whether you need a biopsy. MRI remains the usual first-line scan in the UK, while micro-ultrasound is an emerging option.
If micro-ultrasound is available to you, ask whether it will replace MRI or be used alongside it during your biopsy. The aim is to identify clinically significant cancer accurately while avoiding unnecessary procedures where the evidence supports doing so.
Myth vs Fact
| Myth | Fact |
| Micro-ultrasound can diagnose prostate cancer without a biopsy. | Micro-ultrasound can identify suspicious areas, but prostate cancer usually requires histological confirmation from biopsy tissue. |
| OPTIMUM proved micro-ultrasound is better than MRI. | OPTIMUM demonstrated non-inferiority for detecting Grade Group 2 or higher cancer; it did not prove superiority. |
| OPTIMUM proved targeted micro-ultrasound cores can replace all systematic biopsy samples. | All OPTIMUM groups also received systematic biopsy, so the trial did not establish that targeted micro-US sampling alone is sufficient. |
| Micro-ultrasound and MRI always identify exactly the same lesions. | They can detect overlapping but different lesions. Some cancers may be visible with one technique and less apparent with the other. |
| Micro-ultrasound has already replaced MRI in the UK. | NICE and current European guidance still recommend MRI before biopsy in appropriate patients. Micro-ultrasound remains an emerging option. |
| Micro-ultrasound automatically means the biopsy needle must pass through the rectum. | The imaging probe is generally transrectal, but the biopsy itself can be performed through a transperineal route. |
| A low PRI-MUS score proves biopsy can safely be avoided. | This has not yet been established as routine practice. Further evidence is needed to define when biopsy can safely be omitted based on micro-US. |
Key Takeaways
- Micro-ultrasound provides high-resolution, real-time prostate imaging and uses PRI-MUS to identify suspicious areas.
- OPTIMUM randomised 802 men; 678 underwent biopsy, and micro-ultrasound-guided biopsy was non-inferior to MRI/conventional-ultrasound fusion biopsy for Grade Group 2 or higher cancer.
- All OPTIMUM groups also received systematic biopsy, so the trial did not show that targeted micro-ultrasound cores alone can replace systematic sampling.
- Non-inferiority does not mean micro-ultrasound was better than MRI.
- MRI remains recommended before prostate biopsy in current NICE and EAU guidance.
- MRI and micro-ultrasound can identify different lesions, and operator experience is important.
- If biopsy is needed, current EAU guidance strongly recommends the transperineal route because of lower infectious risk and antibiotic-stewardship considerations.
Frequently Asked Questions
1. What is micro-ultrasound for prostate cancer?
Micro-ultrasound is a high-resolution imaging technique that gives your urologist a detailed, real-time view of your prostate. It can help identify suspicious areas and guide biopsy needles towards them.
2. Is micro-ultrasound better than MRI for prostate cancer?
Not necessarily. The OPTIMUM trial found that micro-ultrasound-guided biopsy was non-inferior to MRI-guided fusion biopsy within the trial’s prespecified margin for detecting clinically significant prostate cancer. However, MRI remains an established part of prostate cancer assessment and is still recommended before biopsy in the UK.
3. Can micro-ultrasound replace an MRI before a prostate biopsy?
Not routinely at present. Micro-ultrasound is an emerging technology, and more evidence is needed before it can replace MRI for all men. Your urologist will consider your individual risk and decide whether MRI, micro-ultrasound or both are appropriate.
4. What is the PRI-MUS score on a micro-ultrasound?
The PRI-MUS score is a system used to assess how suspicious an area of your prostate looks on micro-ultrasound. Scores range from 1 to 5, with higher scores generally indicating a greater likelihood of clinically significant cancer.
5. Can micro-ultrasound find prostate cancer that MRI misses?
It can potentially identify some suspicious areas that may not be clearly visible on MRI. However, micro-ultrasound can also miss some cancers, so researchers are investigating how the two technologies might complement each other.
6. Can micro-ultrasound make prostate biopsy more accurate?
It allows your urologist to target suspicious areas directly using real-time imaging during the procedure. However, accuracy also depends on the operator’s experience and how well suspicious areas can be identified.
7. Could micro-ultrasound reduce the need for unnecessary prostate biopsies?
Potentially, but this has not yet been established for routine use. A suspicious area on micro-ultrasound can still turn out not to be significant cancer, so your overall risk and other test results remain important.
8. Is micro-ultrasound available routinely in the UK?
No. MRI remains the usual first-line imaging test before prostate biopsy in the UK. Micro-ultrasound is available in some specialist centres but has not yet become routine everywhere.
9. Can you have a transperineal biopsy using micro-ultrasound?
Yes. Micro-ultrasound is an imaging and biopsy-targeting technology, while transperineal describes the route used to reach your prostate. Your urologist can use micro-ultrasound to guide a biopsy while using the transperineal approach.
10. Could micro-ultrasound change how prostate cancer is diagnosed in the future?
It could. Micro-ultrasound may offer real-time, high-resolution imaging that allows your urologist to assess and target suspicious areas during the same procedure. However, more research is needed to determine how it should be combined with PSA, MRI and biopsy in routine prostate cancer diagnosis.
Final Thoughts: Understanding the Future of Micro-Ultrasound in Prostate Cancer Diagnosis
Micro-ultrasound could make prostate cancer diagnosis more targeted by giving your urologist detailed, real-time images during your biopsy. However, MRI remains the usual first-line scan before biopsy in the UK, so you should discuss whether micro-ultrasound, MRI or a combination of both is most appropriate for you.
If you would like specialist advice about your prostate health, you can contact our team at Prostate Clinic London to discuss your symptoms, test results and available diagnostic or treatment options.
References:
- National Institute for Health and Care Excellence (NICE) (2019, updated 2021) Prostate cancer: diagnosis and management. NICE guideline NG131. Published 9 May 2019; last updated 15 December 2021. Available at: https://www.nice.org.uk/guidance/ng131
- European Association of Urology (EAU) (2026) EAU Guidelines on Prostate Cancer: Diagnostic Evaluation. 2026 edition. Available at: https://uroweb.org/guidelines/prostate-cancer/chapter/diagnostic-evaluation
- Kinnaird, A., Luger, F., Cash, H. et al. (2025) ‘Microultrasonography-guided vs MRI-guided biopsy for prostate cancer diagnosis: the OPTIMUM randomized clinical trial’, JAMA, 333(19), pp. 1679–1687. Available at: https://jamanetwork.com/journals/jama/fullarticle/2831985
- Ghai, S., Eure, G., Fradet, V., Hyndman, M.E., McGrath, T., Wodlinger, B. and Pavlovich, C.P. (2016) ‘Assessing cancer risk on novel 29 MHz micro-ultrasound images of the prostate: creation of the Micro-Ultrasound Protocol for Prostate Risk Identification’, The Journal of Urology, 196(2), pp. 562–569. Available at: https://pubmed.ncbi.nlm.nih.gov/26791931/
- Micheleto, J.P.C., Suzuki, T.Á., Santos, L.A., Sales, L.P., Lopes, R.I., Martins, B.M., Aguiar Melão, B.V.L., Cordeiro, M.D., Sharour, W., Shabana, W., Nahas, W.C., Ribeiro Filho, L.A. and Suartz, C.V. (2026) ‘Micro-ultrasonography- vs MRI-targeted biopsy in prostate cancer: updated systematic review and meta-analysis’, BJU International, 138(2), pp. 196-207. Available at: https://pubmed.ncbi.nlm.nih.gov/41989063/
- NHS (2025) Tests and next steps for prostate cancer. Last reviewed 31 July 2025. Available at: https://www.nhs.uk/conditions/prostate-cancer/tests-and-next-steps/